CORIOLUS VERSICOLOR

REFERENCIAS

1. Ng TB. A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae). Gen Pharmacol. 1998;30(1):1-4. 

2. Cheng KF, Leung OC. Revisión general de polysaccharopeptides (PSP) de C. versicolor: Los estudios farmacológicos y clínicos. Artículo de Revisión. Feb, 2008

3. Jiménez-Medina E, et al. The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis. BMC Cancer 2008 Mar 24;(8):78. 

4. Harhaji Lj, et al. Anti-tumor effect of Coriolus versicolor methanol extract against mouse B16 melanoma cells: in vitro and in vivo study. Food Chem Toxicol. 2008 May;46(5):1825-33.

5. Ho CY, et al. Coriolus versicolor (Yunzhi) extract attenuates growth of human leukemia xenografts and induces apoptosis through the mitochondrial pathway. Oncol Rep. 2006 Sep;16(3):609-16.

6. Chan SL, Yeung JH. Polysaccharide peptides from COV-1 strain of Coriolus versicolor induce hyperalgesia via inflammatory mediator release in the mouse. Life Sci. 2006 Apr 18;78(21):2463-70.

7. Kenyon J. Observational Non-Controlled Study of the Use of Coriolus versicolor supplementation in 30 Cancer patients. Mycology News 2003 Vol. 1 Edition 7. 

8. Chernev T. Coriolus-MRL supplementation in patients infected with low-risk and high risk HPV subtypes - Bulgarian experience. Poster in 3rd Congress of gynecologist and obstetricians of Macedonia (with international participation) 2013.

9. Couto S. Evaluation of Coriolus versicolor Supplementation in HPV Patients. Clin J of Mycology 2007; 2(1):2-5. 

10. Couto S. Coriolus versicolor en el tratamiento de las lesiones por VPH en el cuello del útero. Revista de Fitoterapia 2009; 9 (suppl 1): 55-58. 

11. Monro J. Cytokine Th1 to Th2 Shift can be Reversed by Coriolus. Prospective Trial for HPV Control with Coriolus. Clinical Journal of Mycology 2005; 1 (Ed. 10): 4.

12. Borisov S. Evaluación de Coriolus MRL en pacientes con HPV de bajo y alto riesgo. Revista Clínica de Micología 2012; 3: 2-3.